To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CXXC5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
296 representative clones for gene CXXC5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BF979465 testis .a -9 to 670 7 to 670   tiling clone,   664/830
(80 %)
29 diff
(96.6 %id)
DB447251 testis .a 3 to 424 1 to 422   tiling clone,   422/422
(100 %)
10 diff
(97.7 %id)
BF980190 testis .a 986 to 1616 654 to 19   tiling clone,   636/654
(97 %)
7 diff
(99.0 %id)
AK001782 ovarian cancer .b 1 to 1640 1 to 1637 A47P S48Q V49W A50Q D51M ... tiling clone, available from FLJ,   1637/1637
(100 %)
2 diff
(99.9 %id)
DA557945   .b 2 to 585 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
AU133662 ovary, tumor tissue .b 2 to 700 2 to 706   capped   705/711
(99 %)
12 diff
(98.4 %id)
CN260766 embryonic stem cells, DMSO-treated H9 cellline .b 8 to 492 7 to 491       485/491
(98 %)
6 diff
(98.8 %id)
BQ890392 dorsal root ganglia .b 10 to 911 1 to 910       910/924
(98 %)
15 diff
(98.4 %id)
CN260759 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 12 to 726 1 to 717       717/717
(100 %)
7 diff
(99.1 %id)
BG700959 brain, hippocampus .b 17 to 612 1 to 595       595/595
(100 %)
7 diff
(98.9 %id)
DB175114 kidney, tumor tissue .b 21 to 568 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DB472211 hippocampus .b 22 to 510 1 to 489       489/489
(100 %)
3 diff
(99.4 %id)
DA371663 thalamus .b 23 to 574 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BG773896 choriocarcinoma, placenta .b 28 to 637 1 to 609       609/609
(100 %)
2 diff
(99.7 %id)
BI256201 cervical carcinoma cell line, cervix .b 30 to 958 1 to 936       936/955
(98 %)
31 diff
(96.8 %id)
DB006349 breast, tumor tissue .b 30 to 558 2 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
DB125112 thymus .b 30 to 577 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
TI_57233286   .b 31 to 909 68 to 949       882/949
(92 %)
28 diff
(97.1 %id)
BI223301 cervical carcinoma cell line, cervix .b 32 to 826 1 to 799       799/799
(100 %)
13 diff
(98.4 %id)
BI906815 leukocyte .b 32 to 909 1 to 881       881/881
(100 %)
22 diff
(97.6 %id)
DA465400   .b 33 to 609 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA577379   .b 33 to 584 2 to 554   capped   553/553
(100 %)
3 diff
(99.5 %id)
DA554246   .b 35 to 592 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BE908405 epithelioid carcinoma, Pancreas .b 36 to 772 1 to 747       747/957
(78 %)
12 diff
(98.8 %id)
TI_57163114   .b 39 to 910 34 to 907       874/909
(96 %)
12 diff
(98.7 %id)
DA270258 caudate nucleus .b 43 to 604 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BI838475 pooled pancreas and spleen .b 43 to 910 1 to 870       870/872
(99 %)
6 diff
(99.4 %id)
CN482666 eye .b 45 to 570 1 to 526       526/526
(100 %)
7 diff
(98.7 %id)
CN481935 eye .b 46 to 638 1 to 593       593/593
(100 %)
4 diff
(99.4 %id)
AA341443 Kidney .b 48 to 221 1 to 174       174/174
(100 %)
0 diff
(100 %id)
CX166218 human embryonic stem cells differentiated toan early endodermal cell type .b 48 to 860 1 to 813   tiling clone,   813/813
(100 %)
0 diff
(100 %id)
AU154898 ovary, tumor tissue .b 1085 to 1640 555 to 1   tiling clone,   555/557
(99 %)
9 diff
(98.4 %id)
AK024338 placenta .c 1 to 1871 1 to 1871 exact tiling clone, available from FLJ,   1871/1871
(100 %)
0 diff
(100 %id)
DA375684 thalamus .c 24 to 345 2 to 323   capped   322/322
(100 %)
0 diff
(100 %id)
DA038189   .c 31 to 343 2 to 314   capped   313/313
(100 %)
0 diff
(100 %id)
DA394969 thalamus .c 31 to 342 2 to 313   capped   312/312
(100 %)
0 diff
(100 %id)
CA392790 eye, RPE/choroid .c 65 to 345 1 to 281       281/281
(100 %)
0 diff
(100 %id)
DA057252 cerebellum .c 68 to 347 2 to 281   capped   280/280
(100 %)
0 diff
(100 %id)
DA146372 amygdala .c 68 to 345 2 to 279   capped   278/278
(100 %)
0 diff
(100 %id)
DA546474   .c 68 to 346 2 to 280   capped   279/279
(100 %)
0 diff
(100 %id)
DA566540 heart .c 68 to 345 2 to 279   capped   278/278
(100 %)
0 diff
(100 %id)
DB245112 uterus, tumor tissue .c 68 to 344 2 to 278   capped   277/277
(100 %)
0 diff
(100 %id)
BC006428 Eye, retinoblastoma .c 70 to 2656 1 to 2587 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 2587/2587
(100 %)
0 diff
(100 %id)
BX404174 neuroblastoma .c 70 to 1073 1 to 999       999/999
(100 %)
20 diff
(98.0 %id)
AL525234 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 73 to 1050 1 to 963       963/1010
(95 %)
27 diff
(97.4 %id)
CR611313 Neuroblastoma Cot 10-normalized .c 74 to 2086 1 to 2013 exact     2013/2013
(100 %)
0 diff
(100 %id)
BX415097 thymus .c 74 to 968 1 to 884   fully sequenced,   884/884
(100 %)
19 diff
(97.9 %id)
AL520003 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 74 to 1054 1 to 963   fully sequenced,   963/963
(100 %)
8 diff
(99.2 %id)
CR614582 fetal brain .c 75 to 1939 1 to 1865 exact     1865/1865
(100 %)
0 diff
(100 %id)
AL539639 brain, fetal brain .c 75 to 980 1 to 906       906/906
(100 %)
5 diff
(99.5 %id)
CD722380 eye, lacrimal gland .c 79 to 344 1 to 266       266/266
(100 %)
0 diff
(100 %id)
BC024040 Placenta, choriocarcinoma .c 80 to 1871 1 to 1792 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 1792/1792
(100 %)
0 diff
(100 %id)
BC041013 Muscle, rhabdomyosarcoma .c 80 to 1871 1 to 1792 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 1792/1792
(100 %)
0 diff
(100 %id)
BM728652 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 80 to 329 1 to 250       250/250
(100 %)
0 diff
(100 %id)
DA262806 caudate nucleus .c 94 to 343 2 to 251   capped   250/250
(100 %)
0 diff
(100 %id)
BM857286 stomach .c 95 to 355 1 to 261       261/261
(100 %)
0 diff
(100 %id)
DA763671 tongue .c 96 to 345 2 to 251   capped   250/250
(100 %)
0 diff
(100 %id)
CV571786 cornea, eye .c 98 to 324 1 to 227       227/227
(100 %)
0 diff
(100 %id)
BC050046 Brain, anaplastic oligodendroglioma with1p/19q loss .c 108 to 1871 1 to 1764 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 1764/1764
(100 %)
0 diff
(100 %id)
BC017439 Lymph, Burkitt lymphoma .c 109 to 1871 1 to 1763 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 1763/1763
(100 %)
0 diff
(100 %id)
CX753114 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 109 to 343 1 to 235       235/235
(100 %)
0 diff
(100 %id)
CN260768 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 115 to 324 1 to 210       210/210
(100 %)
0 diff
(100 %id)
BM797754 Ascites, stomach .c 139 to 342 1 to 204       204/204
(100 %)
0 diff
(100 %id)
BX433211 brain, fetal brain .c 374 to 1134 767 to 8       760/767
(99 %)
10 diff
(98.7 %id)
BI600362 brain, hypothalamus .c 416 to 1197 1 to 782       782/782
(100 %)
10 diff
(98.8 %id)
BI667833 brain, hypothalamus .c 416 to 1219 1 to 812       812/813
(99 %)
20 diff
(97.6 %id)
TI_45215353   .c 421 to 1197 129 to 905       777/905
(85 %)
11 diff
(98.8 %id)
TI_44343948   .c 421 to 1219 90 to 896       807/897
(89 %)
21 diff
(97.7 %id)
AB097005 lung .c 424 to 1871 1 to 1448 exact     1448/1448
(100 %)
1 diff
(100.0 %id)
AB097032 lung .c 424 to 1871 1 to 1448 exact     1448/1448
(100 %)
1 diff
(100.0 %id)
NM_016463.7   .c 425 to 1871 1 to 1447 exact RefSeq,   1447/1447
(100 %)
0 diff
(100 %id)
CN260765 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 434 to 1211 1 to 779       779/779
(100 %)
6 diff
(99.3 %id)
DA178456 amygdala .c 438 to 992 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BF346203 anaplastic oligodendroglioma with 1p/19qloss, brain .c 446 to 1258 1 to 808       808/1093
(73 %)
37 diff
(96.7 %id)
DA747084   .c 452 to 1020 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
TI_57152151   .c 508 to 1439 27 to 949       923/954
(96 %)
48 diff
(95.0 %id)
BI763505 pooled colon, kidney, stomach .c 516 to 1439 1 to 915       915/920
(99 %)
44 diff
(95.3 %id)
BG744073 blood, natural killer cells, cell line .c 550 to 1407 1 to 863       863/940
(91 %)
27 diff
(97.2 %id)
BI760688 pooled colon, kidney, stomach .c 552 to 1445 9 to 902       894/903
(99 %)
19 diff
(97.9 %id)
BQ051544 blood, natural killer cells, cell line .c 552 to 1458 1 to 914       914/979
(93 %)
31 diff
(96.9 %id)
TI_57147833   .c 552 to 1445 42 to 935       894/936
(95 %)
19 diff
(98.0 %id)
BU181795 eye, retinoblastoma .c 553 to 1374 1 to 829       829/931
(89 %)
20 diff
(97.9 %id)
DA961794 Spleen .c 563 to 1118 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA936793 Spleen .c 644 to 1182 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
BU787822 insulinoma, Pancreas .c 651 to 1123 1 to 473     Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 473/473
(100 %)
5 diff
(99.0 %id)
BC002490 Skin, melanotic melanoma. .c 665 to 1871 1 to 1207 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 1207/1207
(100 %)
0 diff
(100 %id)
TI_1948244160   .c 665 to 1615 197 to 1137   AAA   941/1184
(79 %)
26 diff
(97.9 %id)
TI_1948244414   .c 665 to 1637 197 to 1169       973/1235
(78 %)
19 diff
(98.5 %id)
TI_1948244415   .c 665 to 1497 212 to 1049       838/1092
(76 %)
21 diff
(98.1 %id)
TI_1948244679   .c 665 to 1503 197 to 1016       820/1122
(73 %)
25 diff
(97.8 %id)
TI_1948244680   .c 665 to 1409 210 to 953       744/1084
(68 %)
12 diff
(98.9 %id)
TI_1948244946   .c 665 to 1530 210 to 1086       877/1063
(82 %)
40 diff
(96.3 %id)
TI_1948244945   .c 666 to 1811 197 to 1334 L202P N203H P209X Y210L N217X ...     1138/1266
(89 %)
57 diff
(95.5 %id)
DB124601 thymus .c 670 to 1222 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BM543367 duodenal adenocarcinoma, cell line, small intestine .c 674 to 1407 1 to 737   AAA   737/999
(73 %)
11 diff
(98.9 %id)
BE276606 melanotic melanoma, skin .c 684 to 1143 1 to 460       460/460
(100 %)
0 diff
(100 %id)
DN992324 brain, whole brain .c 702 to 1434 1 to 733       733/733
(100 %)
4 diff
(99.5 %id)
GQ379202   .c 715 to 1683 1 to 969 exact     969/969
(100 %)
0 diff
(100 %id)
AK314420   .c 717 to 1683 1 to 967       967/967
(100 %)
0 diff
(100 %id)
DA716896   .c 718 to 1267 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
AY007103   .c 742 to 2354 387 to 1999       1613/1999
(80 %)
6 diff
(99.7 %id)
CN260769 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 752 to 1538 1 to 787       787/787
(100 %)
3 diff
(99.7 %id)
CD627947   .c 774 to 1441 687 to 16       672/687
(97 %)
0 diff
(100 %id)
CB215474 normal endometrium, late proliferativephase, cycle day 13, uterus .c 784 to 1438 1 to 655       655/655
(100 %)
0 diff
(100 %id)
ES311473 frontal balding hair, skin .c 792 to 918 1 to 127       127/127
(100 %)
0 diff
(100 %id)
AF151029 umbilical cord blood .c 793 to 1871 1 to 1077   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 1077/1077
(100 %)
9 diff
(99.2 %id)
DA996484   .c 795 to 1325 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
TI_1948244681   .c 823 to 1891 1114 to 41       1074/1222
(87 %)
47 diff
(96.2 %id)
TI_1948244416   .c 842 to 1891 1100 to 43       1058/1230
(86 %)
33 diff
(97.4 %id)
BF035771 adenocarcinoma, ovary .c 848 to 1510 1 to 662       662/662
(100 %)
1 diff
(99.9 %id)
TI_57242478   .c 880 to 1734 58 to 926       867/926
(93 %)
17 diff
(98.2 %id)
BI917885 brain .c 887 to 1734 1 to 862       860/862
(99 %)
25 diff
(97.1 %id)
TI_1948244163   .c 933 to 1870 1002 to 66       937/1373
(68 %)
16 diff
(98.9 %id)
TI_154102715   .c 935 to 1871 1009 to 86   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 924/995
(92 %)
29 diff
(97.1 %id)
TI_1948244682   .c 937 to 1878 994 to 57       938/1331
(70 %)
18 diff
(98.7 %id)
BX415096 thymus .c 938 to 1844 904 to 1   fully sequenced,   904/904
(100 %)
7 diff
(99.3 %id)
CX787989 human embryonic stem cells .c 947 to 1690 1 to 744       744/744
(100 %)
3 diff
(99.6 %id)
TI_1948244417   .c 963 to 1891 969 to 43       927/1305
(71 %)
7 diff
(99.5 %id)
AW955812   .c 973 to 1735 1 to 768       768/779
(98 %)
24 diff
(97.0 %id)
BI252469 hepatocellular carcinoma, cell line, Liver .c 978 to 1809 1 to 819       819/887
(92 %)
24 diff
(97.3 %id)
BM717856 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 989 to 1483 1 to 495       495/495
(100 %)
0 diff
(100 %id)
AL561842 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 1024 to 2086 1053 to 1   fully sequenced,   1053/1053
(100 %)
16 diff
(98.5 %id)
TI_149312468   .c 1027 to 1871 925 to 89   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 837/964
(86 %)
18 diff
(98.2 %id)
EC495678 Prostate .c 1048 to 1148 98 to 1       98/98
(100 %)
3 diff
(97.0 %id)
BY798508 eye .c 1062 to 1602 1 to 541       541/541
(100 %)
0 diff
(100 %id)
BQ668964 epidermoid carcinoma, cell line, salivary gland .c 1091 to 1835 1 to 742       742/922
(80 %)
16 diff
(98.3 %id)
BQ339225 nervous_normal .c 1094 to 1317 252 to 29       224/252
(88 %)
0 diff
(100 %id)
BI861859 breast, mammary adenocarcinoma, cell line .c 1120 to 1889 15 to 785       771/785
(98 %)
15 diff
(98.1 %id)
TI_57191370   .c 1120 to 1889 70 to 840       771/822
(93 %)
16 diff
(98.1 %id)
BM543418 embryonal carcinoma, cell line, testis .c 1122 to 1838 1 to 721       721/1155
(62 %)
7 diff
(99.4 %id)
AU118733 whole embryo, mainly head .c 1127 to 1899 2 to 772   capped   771/771
(100 %)
6 diff
(99.3 %id)
CF272504 Brain glioblastoma .c 1132 to 2018 1 to 890       890/947
(93 %)
10 diff
(99.0 %id)
CA445667 Chondrosarcoma, Left Pubic Bone .c 1149 to 1871 739 to 17   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 723/723
(100 %)
2 diff
(99.8 %id)
CA308443 Alveolar Macrophage, lung .c 1149 to 1871 739 to 17   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 723/723
(100 %)
2 diff
(99.8 %id)
CA309239 Alveolar Macrophage, lung .c 1183 to 1871 704 to 16   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 689/689
(100 %)
0 diff
(100 %id)
BM682387 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1200 to 1871 688 to 17   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 672/672
(100 %)
0 diff
(100 %id)
TI_151799194   .c 1207 to 1846 748 to 104     Submitted on the opposite strand 645/705
(91 %)
15 diff
(97.9 %id)
BU787547 insulinoma, Pancreas .c 1233 to 1871 653 to 15   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 639/639
(100 %)
0 diff
(100 %id)
BU528384 epidermoid carcinoma, cell line, lung .c 1239 to 1870 678 to 33   AAA Submitted on the opposite strand 646/1003
(64 %)
34 diff
(96.7 %id)
BE938716 testis_normal .c 1254 to 1811 555 to 1       555/555
(100 %)
7 diff
(98.8 %id)
BE844167 testis_normal .c 1265 to 1788 528 to 7       522/528
(98 %)
1 diff
(99.9 %id)
BX411883 neuroblastoma .c 1268 to 2097 838 to 6       833/896
(92 %)
7 diff
(99.3 %id)
BE938720 testis_normal .c 1284 to 1830 545 to 1       545/545
(100 %)
3 diff
(99.5 %id)
AW959125   .c 1330 to 1871 1 to 542   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 542/542
(100 %)
0 diff
(100 %id)
EL950646 eyeball .c 1331 to 1871 1 to 541   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 541/541
(100 %)
0 diff
(100 %id)
AW516068 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1359 to 1874 516 to 1       516/516
(100 %)
0 diff
(100 %id)
BI765525 pooled colon, kidney, stomach .c 1359 to 2204 1 to 848       848/848
(100 %)
3 diff
(99.7 %id)
TI_57152448   .c 1359 to 2204 33 to 880       848/880
(96 %)
9 diff
(99.0 %id)
BP397470 pancreatic islet .c 1372 to 1871 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
AW205784   .c 1376 to 1871 511 to 16   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 496/496
(100 %)
0 diff
(100 %id)
BF593774 brain, glioblastoma (pooled) .c 1376 to 1871 496 to 1       496/496
(100 %)
0 diff
(100 %id)
CD105956 brain, Pituitary .c 1395 to 2274 26 to 915       890/915
(97 %)
22 diff
(97.6 %id)
BE676573 B-cell, chronic lymphotic leukemia .c 1407 to 1872 466 to 1       466/466
(100 %)
0 diff
(100 %id)
BM999151 lung, Lung Focal Fibrosis .c 1420 to 1967 566 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 548/548
(100 %)
0 diff
(100 %id)
AI581278   .c 1426 to 1874 449 to 1       449/449
(100 %)
0 diff
(100 %id)
AI418897 brain, glioblastoma (pooled) .c 1465 to 1871 407 to 1       407/407
(100 %)
0 diff
(100 %id)
BI711336 insulinoma, Pancreas .c 1465 to 1871 422 to 16   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 407/407
(100 %)
0 diff
(100 %id)
CD557041 brain, Pituitary .c 1493 to 2369 1 to 890       890/891
(99 %)
24 diff
(97.4 %id)
CD519603 White Matter .c 1493 to 2226 1 to 745       745/967
(77 %)
18 diff
(98.2 %id)
BE866802 adenocarcinoma, colon .c 1495 to 2259 1 to 773       773/1131
(68 %)
24 diff
(97.9 %id)
AA385998 Pancreas .c 1507 to 1871 365 to 1       365/365
(100 %)
0 diff
(100 %id)
BQ026626 placenta .c 1521 to 1871 366 to 16   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 351/351
(100 %)
0 diff
(100 %id)
AA932838 carcinoid, lung .c 1522 to 1870 349 to 1       349/349
(100 %)
0 diff
(100 %id)
AI002537 carcinoid, lung .c 1524 to 1870 347 to 1       347/347
(100 %)
0 diff
(100 %id)
AA978020 Kidney, kidney tumor .c 1553 to 1871 319 to 1       319/319
(100 %)
0 diff
(100 %id)
AA861149   .c 1559 to 1875 317 to 1       317/317
(100 %)
0 diff
(100 %id)
BG222845 brain, glioblastoma without EGFR amplification .c 1566 to 1874 309 to 1       309/309
(100 %)
0 diff
(100 %id)
BE090318 breast .c 1589 to 2232 637 to 2     Submitted on the opposite strand 636/641
(99 %)
6 diff
(99.1 %id)
AA835679 germinal center B cell .c 1592 to 1871 291 to 12   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 280/280
(100 %)
0 diff
(100 %id)
AL567708 brain, fetal brain .c 1623 to 2617 986 to 1       986/1054
(93 %)
19 diff
(98.2 %id)
BG743446 skin .c 1635 to 2530 1 to 890       890/891
(99 %)
28 diff
(96.9 %id)
BU181878 eye, retinoblastoma .c 1647 to 1871 1 to 225   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 225/225
(100 %)
0 diff
(100 %id)
BU163820 eye, retinoblastoma .c 1647 to 1871 1 to 225   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 225/225
(100 %)
0 diff
(100 %id)
DB541155 hippocampus .c 1655 to 2117 1 to 463     Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
AL562505 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1661 to 2626 961 to 1       961/961
(100 %)
20 diff
(98.0 %id)
AA887599 Kidney .c 1667 to 1858 192 to 1       192/192
(100 %)
0 diff
(100 %id)
AA700174 liver and spleen .c 1668 to 1869 202 to 1       202/202
(100 %)
0 diff
(100 %id)
AA886983 pooled germ cell tumors .c 1668 to 1871 204 to 1       204/204
(100 %)
0 diff
(100 %id)
BG982966 colon_normal .c 1682 to 2227 552 to 7       546/563
(96 %)
0 diff
(100 %id)
AI799375 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1688 to 1871 184 to 1       184/184
(100 %)
0 diff
(100 %id)
BQ188424 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1699 to 2213 1 to 515   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 515/515
(100 %)
0 diff
(100 %id)
AW167067 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1705 to 2214 510 to 1       510/510
(100 %)
0 diff
(100 %id)
CD677381 eye, Trabecular meshwork .c 1735 to 2225 1 to 491       491/525
(93 %)
1 diff
(99.9 %id)
AA970565 Kidney, kidney tumor .c 1735 to 1872 138 to 1       138/138
(100 %)
0 diff
(100 %id)
AW903022 nervous_normal .c 1746 to 2066 326 to 5       322/333
(96 %)
0 diff
(100 %id)
BE180904 head_neck .c 1746 to 2154 439 to 28     Submitted on the opposite strand 412/446
(92 %)
0 diff
(100 %id)
AA703148 liver and spleen .c 1754 to 1874 121 to 1       121/121
(100 %)
0 diff
(100 %id)
BP420346 small intestine .c 1780 to 2365 1 to 586     Submitted on the opposite strand 586/586
(100 %)
0 diff
(100 %id)
BM831326 stomach .c 1798 to 2437 1 to 640       640/640
(100 %)
0 diff
(100 %id)
W32401.
matches multiple genes
parathyroid gland, parathyroid tumor .c 1801 to 2221 421 to 1     also hits gene sharvyby 421/421
(100 %)
0 diff
(100 %id)
BG744741 blood, natural killer cells, cell line .c 1823 to 2607 787 to 1       787/787
(100 %)
2 diff
(99.8 %id)
AA463784   .c 1850 to 2115 1 to 266       266/266
(100 %)
0 diff
(100 %id)
BY797835 eye .c 1855 to 2475 1 to 621       621/621
(100 %)
0 diff
(100 %id)
CB242885 Human Lung Epithelial cells, lung .c 1871 to 2656 803 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 785/794
(98 %)
2 diff
(99.8 %id)
TI_154115874   .c 1872 to 2656 859 to 83   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 777/800
(97 %)
17 diff
(97.9 %id)
BQ130899 insulinoma, Pancreas .c 1873 to 2219 2 to 348   fully sequenced, Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 347/348
(99 %)
4 diff
(98.9 %id)
BQ267561 insulinoma, Pancreas .c 1873 to 2389 2 to 518   fully sequenced, Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 517/518
(99 %)
4 diff
(99.3 %id)
AW602766 breast .c 1884 to 2398 519 to 5       515/522
(98 %)
0 diff
(100 %id)
BM709161 eye, optic nerve .c 1887 to 2384 1 to 498   fully sequenced, Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 498/498
(100 %)
0 diff
(100 %id)
BU608871 Human Lung Epithelial cells, lung .c 1901 to 2550 13 to 661     Submitted on the opposite strand 649/661
(98 %)
6 diff
(99.1 %id)
AA902487 carcinoid, lung .c 1907 to 2325 1 to 419     Submitted on the opposite strand 419/419
(100 %)
0 diff
(100 %id)
BE093087 breast .c 1908 to 2137 240 to 12     Submitted on the opposite strand 229/240
(95 %)
0 diff
(100 %id)
CA306824 Alveolar Macrophage, lung .c 1908 to 2656 767 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 749/749
(100 %)
1 diff
(99.9 %id)
BQ716221 sympathetic trunk .c 1910 to 2656 1 to 749   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 749/749
(100 %)
2 diff
(99.8 %id)
AA131895 uterus .c 1914 to 2360 1 to 447   fully sequenced,   447/447
(100 %)
0 diff
(100 %id)
AA150657 uterus .c 1914 to 2303 1 to 389   fully sequenced,   389/389
(100 %)
1 diff
(99.8 %id)
AA147496 uterus .c 1914 to 2244 1 to 332   fully sequenced,   332/332
(100 %)
0 diff
(100 %id)
BQ006668 Chondrosarcoma, Left Pelvis .c 1914 to 2656 761 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 743/743
(100 %)
3 diff
(99.6 %id)
AA133356 uterus .c 1921 to 2658 1 to 735       735/744
(98 %)
6 diff
(99.2 %id)
CA314019 Human Lung Epithelial cells, lung .c 1922 to 2319 31 to 428     Submitted on the opposite strand 398/435
(91 %)
1 diff
(99.8 %id)
AA903576 pooled germ cell tumors .c 1924 to 2357 434 to 1       434/434
(100 %)
0 diff
(100 %id)
H48306 liver and spleen .c 1932 to 2344 1 to 418   fully sequenced,   418/418
(100 %)
3 diff
(99.3 %id)
C03401 heart .c 1946 to 2278 1 to 333       333/333
(100 %)
0 diff
(100 %id)
BM826699 Ascites, stomach .c 1954 to 2484 1 to 531       531/531
(100 %)
0 diff
(100 %id)
CU445950 epidermis .c 1962 to 2320 372 to 14     Submitted on the opposite strand 359/381
(94 %)
0 diff
(100 %id)
AA769542 germinal center B cell .c 1976 to 2373 431 to 34   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 398/398
(100 %)
0 diff
(100 %id)
AW602750 breast .c 2003 to 2390 394 to 11       384/411
(93 %)
0 diff
(100 %id)
BE075792 breast .c 2039 to 2318 294 to 14     Submitted on the opposite strand 281/294
(95 %)
0 diff
(100 %id)
BU608121 Human Lung Epithelial cells, lung .c 2040 to 2656 635 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 617/626
(98 %)
0 diff
(100 %id)
AI364857 ovary, tumor, 5 pooled (see description) .c 2041 to 2197 157 to 1       157/157
(100 %)
0 diff
(100 %id)
DB356914 whole embryo, mainly head .c 2087 to 2656 570 to 1       570/570
(100 %)
5 diff
(99.2 %id)
FN110106 breast carcinoma .c 2088 to 2196 109 to 1     Submitted on the opposite strand 109/109
(100 %)
0 diff
(100 %id)
H49297 brain .c 2115 to 2517 1 to 409       409/409
(100 %)
9 diff
(97.8 %id)
H46879 brain .c 2116 to 2389 1 to 278   fully sequenced,   278/278
(100 %)
0 diff
(100 %id)
BQ575390 Chondrosarcoma Grade II, Left Pelvis .c 2139 to 2656 536 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 518/518
(100 %)
0 diff
(100 %id)
H23923 brain .c 2150 to 2541 1 to 397       397/397
(100 %)
10 diff
(97.5 %id)
AW339430 carcinoid, lung .c 2154 to 2432 279 to 1       279/289
(96 %)
17 diff
(94.2 %id)
DB542008 hippocampus .c 2176 to 2656 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
BQ130634 insulinoma, Pancreas .c 2189 to 2656 486 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 468/468
(100 %)
0 diff
(100 %id)
DB540964 hippocampus .c 2193 to 2653 1 to 461     Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
AA371997 pituitary gland .c 2195 to 2418 1 to 224       224/234
(95 %)
2 diff
(99.2 %id)
AI669635 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 2195 to 2653 471 to 13   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 459/459
(100 %)
0 diff
(100 %id)
AW953840   .c 2196 to 2653 1 to 458   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 458/458
(100 %)
0 diff
(100 %id)
DB546080 hippocampus .c 2205 to 2655 1 to 451     Submitted on the opposite strand 451/451
(100 %)
0 diff
(100 %id)
AA156233 uterus .c 2214 to 2664 444 to 1   fully sequenced,   444/444
(100 %)
6 diff
(98.7 %id)
AI089697 brain, glioblastoma (pooled) .c 2227 to 2656 441 to 12   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 430/430
(100 %)
0 diff
(100 %id)
BI049806 placenta_normal .c 2253 to 2543 16 to 307       292/307
(95 %)
6 diff
(98.1 %id)
AI130933 heart .c 2253 to 2656 404 to 1       404/404
(100 %)
0 diff
(100 %id)
BF753683 colon .c 2256 to 2434 1 to 179       179/179
(100 %)
1 diff
(99.5 %id)
BF753684 colon .c 2256 to 2434 1 to 179       179/179
(100 %)
1 diff
(99.5 %id)
AI336099 lung .c 2263 to 2654 392 to 1       392/392
(100 %)
0 diff
(100 %id)
AI968955 brain, four pooled pituitary adenomas .c 2263 to 2657 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AI054279 ovary, papillary serous carcinoma .c 2268 to 2354 111 to 25   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 87/100
(87 %)
3 diff
(97.0 %id)
AA142950 uterus .c 2273 to 2664 386 to 1   fully sequenced,   386/386
(100 %)
5 diff
(98.8 %id)
BF931904 nervous_tumor .c 2276 to 2561 332 to 50     Submitted on the opposite strand 283/332
(85 %)
0 diff
(100 %id)
BE041886 borderline ovarian carcinoma, ovary .c 2276 to 2346 1 to 71       71/71
(100 %)
0 diff
(100 %id)
CB857771 anterior tongue, pooled .c 2282 to 2656 1 to 375   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 375/375
(100 %)
0 diff
(100 %id)
AI168042 parathyroid gland, parathyroid tumor .c 2292 to 2656 378 to 14   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 365/365
(100 %)
0 diff
(100 %id)
H48214 liver and spleen .c 2314 to 2632 322 to 1   fully sequenced,   322/322
(100 %)
6 diff
(98.2 %id)
AI421144 brain, glioblastoma (pooled) .c 2320 to 2656 337 to 1       337/337
(100 %)
0 diff
(100 %id)
AW273768 lung, two pooled squamous cell carcinomas .c 2326 to 2656 343 to 13   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 331/331
(100 %)
0 diff
(100 %id)
AA131896 uterus .c 2330 to 2664 333 to 1   fully sequenced,   333/333
(100 %)
7 diff
(97.9 %id)
BU732217 eye, optic nerve .c 2354 to 2656 321 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 303/303
(100 %)
3 diff
(99.1 %id)
AA659687 normal prostate, Prostate .c 2357 to 2511 155 to 1       155/155
(100 %)
1 diff
(99.4 %id)
H46299 brain .c 2359 to 2628 277 to 1   fully sequenced,   277/277
(100 %)
2 diff
(99.3 %id)
BQ272249 insulinoma, Pancreas .c 2359 to 2656 316 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 298/298
(100 %)
1 diff
(99.7 %id)
AI619564 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 2430 to 2658 229 to 1       229/229
(100 %)
0 diff
(100 %id)
T24576   .c 2458 to 2655 192 to 3       190/192
(98 %)
0 diff
(100 %id)
AI580364 Kidney .c 2465 to 2656 192 to 1       192/192
(100 %)
0 diff
(100 %id)
BU187119 eye, retinoblastoma .c 2528 to 2660 1 to 133   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 133/133
(100 %)
0 diff
(100 %id)
CD639611 pooled .c 2549 to 2655 1 to 107   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 107/107
(100 %)
3 diff
(97.2 %id)
DB453465 testis .d 1 to 506 1 to 508   tiling clone,   508/508
(100 %)
5 diff
(99.1 %id)
BI464701 testis .d 32 to 842 1 to 817   tiling clone,   817/820
(99 %)
41 diff
(95.0 %id)
BI828094 brain, medulla .d 58 to 882 1 to 838   tiling clone,   838/841
(99 %)
25 diff
(97.1 %id)
TI_57172945   .d 58 to 882 69 to 906       838/909
(92 %)
31 diff
(96.6 %id)
DB093282 testis .d 60 to 617 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
BU742590 eye, fetal eye .d 824 to 1451 626 to 1   tiling clone,   626/626
(100 %)
7 diff
(98.9 %id)
BG716148 brain, hypothalamus .e 1 to 581 7 to 587 L32I L61M H66N tiling clone,   587/590
(99 %)
9 diff
(98.5 %id)
DA170918 amygdala .e 1 to 557 2 to 558 exact tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
DA543176   .e 29 to 579 2 to 552 exact tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
BU539350 adenocarcinoma, cell line, breast .f-u 1 to 815 1 to 820 exact tiling clone,   820/894
(91 %)
9 diff
(99.0 %id)
R82768 placenta .f-u 378 to 629 1 to 254   fully sequenced,   254/254
(100 %)
2 diff
(99.3 %id)
BG686690 B-cells, primary B-cells from tonsils (cell line) .f-u 430 to 1211 1 to 779   tiling clone,   779/781
(99 %)
9 diff
(98.9 %id)
AA873015 germinal center B cell .f-u 521 to 1035 517 to 5   tiling clone,   513/517
(99 %)
0 diff
(100 %id)
AW117276 pooled .f-u 551 to 1024 474 to 1       474/474
(100 %)
0 diff
(100 %id)
H00617 placenta .f-u 599 to 1007 412 to 1   fully sequenced,   412/412
(100 %)
5 diff
(98.8 %id)
BF591256 colon, colon tumor, RER+ .f-u 618 to 1029 412 to 2       411/412
(99 %)
0 diff
(100 %id)
AA699638 liver and spleen .f-u 623 to 1022 401 to 1       401/401
(100 %)
1 diff
(99.8 %id)
BM009646 amelanotic melanoma, cell line, skin .f-u 659 to 1434 1 to 772   tiling clone,   772/772
(100 %)
10 diff
(98.8 %id)
TI_59384409   .f-u 660 to 1434 59 to 829       771/771
(100 %)
9 diff
(98.9 %id)
AA729420 pooled germ cell tumors .f-u 671 to 1024 354 to 1       354/393
(90 %)
0 diff
(100 %id)
AI351776 pooled germ cell tumors .f-u 671 to 1024 354 to 1       354/410
(86 %)
3 diff
(99.3 %id)
AI961898 adenocarcinoma, Pancreas .f-u 727 to 1008 282 to 1       282/282
(100 %)
0 diff
(100 %id)
DA705695   .g 1 to 502 2 to 503 exact tiling clone, capped   502/502
(100 %)
0 diff
(100 %id)
BI460400 testis .h 1 to 650 1 to 650   tiling clone,   650/652
(99 %)
12 diff
(98.2 %id)
TI_57170584   .h 1 to 899 47 to 944       898/946
(94 %)
17 diff
(98.3 %id)
DB446400 testis .h 9 to 461 1 to 452       452/452
(100 %)
12 diff
(97.4 %id)
DB458723 testis .h 9 to 459 1 to 451       451/451
(100 %)
0 diff
(100 %id)
CR748992 brain, medulla .h 22 to 463 1 to 441       441/441
(100 %)
1 diff
(99.8 %id)
BI825360 brain, medulla .h 22 to 899 1 to 879   tiling clone,   879/881
(99 %)
7 diff
(99.3 %id)
BM718892 eye, fetal eye .h 192 to 871 6 to 685   fully sequenced, Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 680/685
(99 %)
6 diff
(99.2 %id)
H73141 liver and spleen .h 646 to 971 1 to 324   tiling clone,   324/324
(100 %)
13 diff
(96.0 %id)
DA027432   .h 770 to 1296 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
BM680755 eye, fetal eye .h 841 to 1536 712 to 17   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 696/696
(100 %)
0 diff
(100 %id)
H74233 liver and spleen .h 1155 to 1537 398 to 13       386/421
(91 %)
5 diff
(98.9 %id)
BI763590 pooled colon, kidney, stomach .i 1 to 731 1 to 734 S3R V4C R5A G6A R7G ... tiling clone,   734/891
(82 %)
28 diff
(96.9 %id)
TI_57152095   .i 1 to 731 66 to 799 R7G G8A R9G S10V S11R ...     734/956
(76 %)
31 diff
(96.8 %id)
CB140368 Liver .j 1 to 587 1 to 587   tiling clone,   587/587
(100 %)
2 diff
(99.7 %id)
DA711211   .j 7 to 545 9 to 547   capped   539/539
(100 %)
0 diff
(100 %id)
BX509689   .j 40 to 637 1 to 598 P78X A110P A111V S113X H119R tiling clone,   598/601
(99 %)
6 diff
(99.1 %id)
DA914310   .j 43 to 599 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA031665   .k 1 to 580 2 to 584 E30* tiling clone, capped   583/583
(100 %)
6 diff
(99.0 %id)
DA931287 Spleen .k 14 to 570 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA652852   .k 40 to 573 2 to 535   tiling clone, capped   534/534
(100 %)
0 diff
(100 %id)
DA264868 caudate nucleus .l 1 to 567 2 to 568   tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
CB155750 brain .l 47 to 570 1 to 524 exact tiling clone,   524/524
(100 %)
0 diff
(100 %id)
DA291558 hippocampus .m 1 to 471 2 to 472 exact tiling clone, capped   471/471
(100 %)
0 diff
(100 %id)
CN260760 embryonic stem cells, DMSO-treated H9 cellline .n 1 to 442 1 to 442 exact tiling clone,   442/442
(100 %)
0 diff
(100 %id)
BG014722 placenta_normal .o-u 1 to 165 165 to 1   tiling clone,   165/165
(100 %)
0 diff
(100 %id)
BG014760 placenta_normal .o-u 3 to 169 172 to 3       170/172
(98 %)
0 diff
(100 %id)
BE171400 head_neck Gene CXXC5, variant not shown              
DA104152 cerebellum Gene CXXC5, variant not shown       capped      
DB300282 cerebellum Gene CXXC5, variant not shown              
DA117735 cerebellum Gene CXXC5, variant not shown       capped      
CN414163 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells Gene CXXC5, variant not shown              
BX436900 thymus Gene CXXC5, variant not shown              
BX436901 thymus Gene CXXC5, variant not shown              
BC013025 Muscle, rhabdomyosarcoma Gene CXXC5, variant not shown       AAA Suspected internal deletion, this clone was ignored    
392 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h, .i, .j, .k, .l, .m, .n, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI